Mark E Cooper — ASN Events
  1. Schedule
  2. Mark E Cooper

Mark Cooper

Monash university, VIC, Australia

  • This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:

Effects of linagliptin on glycemic control and albuminuria in type 2 diabetes - the MARLINA–T2D™ trial (#62)

5:00 PM
Per-Henrik Groop
ADS Clinical Orals - Type 2 Therapies